SNHG15 and urinary bladder carcinoma: These insights not only offer new avenues for molecular classification and non-invasive prognostic assessment of bladder cancer (e.g., the SNORS model), but also suggest potential targeted therapies, such as inhibiting SNHG1 or targeting SNHG15-SEs.